secwatch.observer — SEC 8-K summary
======================================

Issuer:     ORAMED PHARMACEUTICALS INC. (ORMP)
CIK:        0001176309
Form:       8-K
Filed at:   2026-02-20T23:59:59+00:00
Accession:  0001012975-26-000195
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Oramed receives warrant to buy 100k Scilex shares at $20 in exchange for deferring amortization payment
--------------------------------------------------------------------------------

- Oramed deferred its right to receive an amortization payment from Scilex due Oct 1, 2025; payment was made in Nov 2025.
- Oramed received a warrant to purchase 100,000 shares of Scilex common stock at $20.00 per share, expiring Dec 13, 2029.
- Warrant issued under Section 4(a)(2) and Rule 506(b); Scilex agreed to file resale registration statement.
- Beneficial ownership limited to 4.99% (can be raised to 9.99% with 61 days' notice).
- Warrant immediately exercisable; exercise price subject to anti-dilution adjustments with floor of $8.22.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1176309/000101297526000195/0001012975-26-000195-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1176309/000101297526000195/ormp-20260219.htm
  HTML page:      https://secwatch.observer/filing/0001012975-26-000195

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer